Session 1:
Ansgar Schulz, Friedrich Loeffler Institute, Germany
Whole genome sequencing of various bunyaviruses and other arboviruses using MinION nanopore technology
Igor Starinskij, MRC-University of Glasgow Centre for Virus Research, United Kingdom
Research tools for Erve virus, a neglected European nairovirus
Jorlan Fernandes, Universidade do Estado do Rio de Janeiro and Fundação Oswaldo Cruz,
Brazil Old reservoirs, New Virus – The diversity of Mammarenavirus in Brazil.
Pritesh Lalwani, Instituto Leônidas e Maria Deane and Fundação Oswaldo Cruz, Brazil
Oropouche Virus Resurgence: Investigating the Role of a Novel Reassortant in Brazil
Nazif Elaldi, Sivas Cumhuriyet University, Turkey Crimean-Congo
Haemorrhagic Fever Virus Diversity, Clinical Severity, Blood Virus Titres and Outcomes, Turkey, 2020–2021
Session 2:
Gaya Amarasinghe, Washington University School of Medicine, USA
Role of LDL related receptor proteins in bunyaviral infection
Solene Denolly, Centre International de Recherche en Infectiologie, France
The low-density lipoprotein receptor and apolipoprotein E associated with CCHFV particles mediate CCHFV entry into cells
Aseel Alyahyawi, University of Leeds, United Kindgom
Investigating the entry mechanisms of a new member of the Orthobunyavirus genus
Lennart Sänger, Bernhard Nocht Institute for Tropical Medicine, Germany
An RNA to Rule Them All: Critical Steps in Lassa Virus Ribonucleoparticle Assembly and Recruitment
Juan Oswaldo Concha Casaverde, University of Sao Paulo, Brazil
The host factors Rab27a and Myosin Va are required for efficient cell egress of Oropouche virus
François-Loïc Cosset, Centre International de Recherche en Infectiologie, France
The PACS-2 protein and trafficking motifs in CCHFV Gn and Gc cytoplasmic tails govern CCHFV assembly
Nicole Tischler, Fundación Ciencia & Vida – University of San Sebastián, Chile
Molecular insights into the hantavirus Gn/Gc spikes during viral cell:cell transmission, cell entry and their biogenesis
Session 3:
Catherine Beauchemin, Interdisciplinary Theoretical and Mathematical Sciences Program, RIKEN, Japan
A framework to individually measure virus replication steps and identify experimental artifacts
Kate Gilroy, University of Leeds, United Kingdom
Developing a Molecular Toolkit for the Live Cell Investigation of Arenavirus Replication
Alejandro Brun, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, CSIC, Spain
Novel replication-competent Rift Valley fever viruses expressing fluorescent or bioluminescent reporter genes
Harry Williams, Bernhard Nocht Institute for Tropical Medicine, Germany
Structural snapshots of phenuivirus cap-snatching and transcription
Jeremy Keown, University of Warwick, United Kingdom
Structural characterisation of the CCHFV polymerase
Eurico De Arruda Neto, University of São Paulo, Brazil
The tropical phlebovirus Candiru replicates in human cell lines and causes apoptosis of HuH-7 liver cells by both intrinsic and extrinsic pathways
Yeonjae Lee, University of Leeds, United Kingdom
Investigating the structure and function of bunyavirus ribonucleoproteins
Piotr Gerlach, IMOL - Polish Academy of Sciences, Poland
Preliminary insight into La Crosse orthobunyavirus transcription termination mechanism
Session 4:
Clayton Winkler, National Institute of Allergy and Infectious Diseases, NIH, USA
CCR2 and CCR7 synergistically control inflammatory monocyte recruitment during La Crosse virus encephalitis but monocyte immunological function in the brain is impaired
Younho Choi, Cleveland Clinic Florida Research and Innovation Center, USA
The NSs of SFTSV inhibits the human antiviral RNAi pathway through its interaction with Ago2
José Luiz Proenca Modena, University of Campinas, Brazil
B-cell response against Oropouche virus
Stephen Graham, University of Cambridge, United Kingdom
A protein-based molecular toolkit to study, detect, prevent and treat Oropouche fever
Deepashri Rao, National Institute of Allergy and Infectious Diseases, NIH, USA
Signaling through TNFR1 is required for survival in Crimean-Congo hemorrhagic fever virus infection
Benjamin Nilsson-Payant, TWINCORE Centre for Experimental and Clinical Infection Research, Germany
Molecular basis of hantavirus defective viral genomes in innate immune regulation
Moshe Dessau, Bar Ilan University, Israel
Structural investigation of RNA silencing suppressors from an Emaravirus
Session 5:
Esther Schnettler, Bernhard Nocht Institute for Tropical Medicine, Germany
Dicer 2 mutations in Aedes aegypti cells lead to a diminished antiviral function against RVFV and BUNV infection
Samantha Clark, Louisiana State University, USA
The good, the BATV, and the ugly: first evaluation of BATV vector competence in Louisiana mosquitoes
Marine Petit, University of Surrey, United Kingdom
Temporal multi-omics analysis of Severe Fever with Thrombocytopenia syndrome virus (SFTSV) infection in tick cells reveal novel antiviral effectors.
Patrick Höller, Bernhard Nocht Institute for Tropical Medicine. Germany
Unveiling Tahyna Virus Transmission: Vector Competence of Mosquitoes from Europe
Eurico De Arruda Neto, University of São Paulo, Brazil
Vertical transmission of Oropouche virus in C57BL/6 mice and infection of murine and human trophoblasts
Session 6:
David Hawman, National Institute of Allergy and Infectious Diseases, NIH, United Kingdom
Antibodies against the CCHFV nucleoprotein require the intracellular Fc-receptor TRIM21 for protection.
Belen Borrego, Center for Animal Health Research, National Center for Agricultural and Food Research and Technology, CSIC, Spain
Dynamics of the potential attenuating mutations of the RVF vaccine candidate 40Fp8 in the absence of (efficient) immune responses
Paul Wichgers Schreur, Wageningen Bioveterinary Research and BunyaVax, Netherlands
Safety and immunogenicity of the live-attenuated hRVFV-4s Rift Valley fever vaccine in healthy adults
Darryl Falzarano, Vaccine and Infectious Disease Organization, Canada
Differential Glycosylation Profiles of Lassa Virus GPC in Expi293 and ExpiCHO Suspension Cultures – Implications for Subunit Vaccine Production
Virginia Aida-Ficken, Centers for Disease Control and Prevention and Auburn University College of Veterinary Medicine, USA
Inhibiting the Lassa Virus Polymerase with a Novel Macrocyclic Compound
Peter Hart, Coalition for Epidemic Preparedness Innovations, United Kingdom
The Coalition for Epidemic Preparedness Innovations (CEPI): A Global coalition to develop vaccines for epidemics and pandemics.